The Food and Drug Administration (FDA) has granted traditional approval to Retevmo ® (selpercatinib) for adult and pediatric patients 2 years and older with advanced or metastatic medullary thyroid ...

HealthDay News — The free COVID-19 tests promised by the US government are now available. “US households will be eligible to order four free COVID-19 tests at COVIDTests.gov ,” according to the US ...

The American Academy of Pediatrics (AAP) has published its first clinical practice guideline on the use of opioid medications to manage acute pain in children and adolescents.

Significantly greater reduction from baseline seen in Wang bronchiolitis clinical score at day 3 for those aged 1 to 24 months ...

Coverage lower for those covered by Medicaid or other nonprivate insurance, uninsured children, children living below federal poverty level ...

HealthDay News — Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of the ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

HealthDay News — In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in ...

"Children are the overlooked tragic victims of the United States' opioid epidemic, and fentanyl is now the greatest danger." HealthDay News — Opioid poisonings are increasing among children, according ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S ...

Xanomeline and trospium chloride is a first-in-class medication that selectively targets the M1 and M4 receptors without blocking D2 receptors.